Clinical trial
Amniochorionic Membrane Cells in the Maternal Blood as a Biomarker for Preterm Birth
NCT04705935 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Amniochorionic Membrane Cells in the Maternal Blood as a Biomarker for Preterm Birth
- Lead sponsor
- University of Aarhus
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 15, 2022
- Completion date
- June 28, 2024
- Enrollment
- 83 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
preterm birth, preterm labor, preterm premature rupture of membrane